Margaret Kyle

MINES ParisTech
Professor of economics

Margaret currently holds the Chair in Markets for Technology and Intellectual Property at MINES ParisTech. She is an associate editor at the International Journal of Industrial Organization and a Research Fellow at the Centre for Economic Policy. She previously held positions at Carnegie Mellon University, Duke University, London Business School and the Toulouse School of Economics. She has also been a visiting scholar at the University of Hong Kong and Northwestern University.

Linked authors

Compass Lexecon (Paris)
King’s College (London)
British Competition Authority - CMA (London)
DG COMP (Brussels)
Barclays (London)
British Competition Authority - CMA (London)
King’s College (London)
Cleary Gottlieb Steen & Hamilton (London)

Articles

1161 Bulletin

Margaret Kyle Competition in the pharmaceutical sector: An overview of EU and national case law

1161

The pharmaceutical sector regularly attracts the attention of competition authorities, who note persistently high profits, waves of merger activity, and declining research productivity in the presence of concerns about affordable access to treatments. The reliance on intellectual property rights (IPRs) introduces some complications to the analysis of pharmaceutical markets, as the welfare losses associated with entry barriers and high prices must be balanced against the dynamic effects of innovation incentives. In addition, the manner in which the pharmaceutical industry is regulated in Europe – with a mix of pan-EU and national policies and institutions – can lead to challenges in reconciling the goal of a “single market” with national needs, and in using competition law to achieve particular aims.

Send a message